Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research
In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR
Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says
DCCR Community Oncology Program RFP Now Ready
NCI Statisticians Disputes Bross Claim
Pauling Contends His Applications Included Essentials
Rall, FDA Chief On AACR Panel
Trending Stories
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Pour a Scotch, we’re talking clinical trials and prediction markets
- Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









